ADMISSION is a new Research Collaborative funded by the MRC and NIHR that brings together scientists, clinicians and patients from five UK universities and hospitals (Newcastle, Birmingham, Manchester Metropolitan, University College London and Dundee) to transform understanding of multiple long-term conditions in hospital patients.
Living with multiple long-term conditions, also known as multimorbidity, is very common among people admitted to hospital. These patients often stay in hospital for longer, are more likely to die and, for patients who recover, this may take much longer. However, the way that care is delivered in hospital is not ideal; in a system that was designed for the treatment of single conditions, the care of patients with multimorbidity can be unsatisfactory, inefficient and expensive. To date there has been little research on multimorbidity in hospital patients which is crucial to understand how services need to be changed.
Harnessing the power of ‘big data’ from routinely-collected hospital, primary and social care records, along with research studies such as UK Biobank and the Scottish Health Research Register (SHARE), ADMISSION will use cutting-edge data science, computing and statistical techniques, care pathway analysis, qualitative methods, genetic epidemiology and phenotypic characterisation. This will enable identification of clusters of long-term conditions in hospital patients, the occurrence of inequalities, the biological causes underlying these clusters, and their consequences.
ADMISSION will lay foundations for new approaches to the recognition and treatment of multimorbidity in hospital and inform the design of future care, with potential to improve health outcomes for the millions of patients with multimorbidity admitted to hospital each year.
This website will be updated with further information about ADMISSION soon, including information on upcoming job vaccancies. Please follow us on Twitter for the latest updates @AdmissionCollab
For further information on the funding award and UKRI Multimorbidity/multiple long-term conditions initiative please click here.